Nicholas David Lakin

Title: Innovations of Nicholas David Lakin

Introduction

Nicholas David Lakin is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, particularly in understanding the interactions of key proteins involved in DNA damage response.

Latest Patents

Lakin holds a patent titled "Interactions of ATM, ATR or DAN-PK with p53." This patent discloses the interaction of ATM and related protein kinases such as ATR and DNA-PK with p53. It particularly focuses on the phosphorylation of Ser15 and Thr18 by these proteins. The activity of these proteins is shown to increase in the presence of DNA. The patent also provides assays for modulators of phosphorylation by the interaction between the proteins and p53 or other proteins with similar phosphorylation sites. Additionally, methods of purifying ATM or ATR employing DNA or NTA are disclosed. Lakin has 1 patent to his name.

Career Highlights

Nicholas Lakin is associated with Kudos Pharmaceuticals Limited, where he continues to advance his research and innovations. His work has implications for understanding cancer biology and therapeutic development.

Collaborations

Lakin has collaborated with notable colleagues in his field, including Stephen Philip Jackson and Graeme Cameron Murray Smith. Their combined expertise contributes to the advancement of research in protein interactions and their implications in cellular processes.

Conclusion

Nicholas David Lakin's contributions to the field of biochemistry through his patent and collaborations highlight his role as an innovator in understanding protein interactions. His work continues to influence research in DNA damage response and therapeutic strategies.